
A new editorial team for Revista Española de Cardiología (Rev Esp Cardiol) was appointed at the Cardiovascular Disease Congress of October 2021, following the statutory 6-year incumbency of the previous team.1 It is only fitting to begin this “Editor's page” with an acknowledgement of the tremendous work of the previous team. Beyond the peak impact factor (IF) of, 5.166, achieved in 2017, the main accomplishment has been the comfortable consolidation of the IF above 4 (range, 4.485-5.166). The impact of Rev Esp Cardiol is unequivocally illustrated by the progressive growth in external citations, which reached 78% in the last year.2Table 1 shows the articles published in the journal in recent years with the greatest impact while Table 2 lists the articles receiving awards from the Spanish Society of Cardiology in 2021.
Research articles, reviews, and position papers published in Revista Española de Cardiología in 2018, 2019, 2020, and 2021 with the greatest impact*
Year | Title | Type of publication | Total citations |
---|---|---|---|
2018 | Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVE’, SECOT and AEU3 | Position paper | 50 |
Association Between a Healthy Lifestyle Score and the Risk of Cardiovascular Disease in the SUN Cohort4 | Original article | 31 | |
Spanish Cardiac Catheterization and Coronary Intervention Registry. 27th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2017)5 | Special article | 24 | |
Spanish Catheter Ablation Registry. 17th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2017)6 | Special article | 23 | |
Comparison of the Hemodynamic Performance of the Balloon-expandable SAPIEN 3 Versus Self-expandable Evolut R Transcatheter Valve: A Case-matched Study7 | Original article | 22 | |
Association of General and Abdominal Obesity With Hypertension, Dyslipidemia and Prediabetes in the PREDAPS Study8 | Original article | 22 | |
Tako-tsubo Syndrome in Men: Rare, but With Poor Prognosis9 | Original article | 20 | |
2019 | Recommendations of the Geriatric Cardiology Section of the Spanish Society of Cardiology for the Assessment of Frailty in Elderly Patients With Heart Disease10 | Special article | 38 |
Vasoactive Inotropic Score as a Predictor of Mortality in Adult Patients With Cardiogenic Shock: Medical Therapy Versus ECMO11 | Original article | 34 | |
Excess Weight in Spain: Current Situation, Projections for 2030, and Estimated Direct Extra Cost for the Spanish Health System12 | Original article | 31 | |
Applications of Artificial Intelligence in Cardiology. The Future is Already Here13 | Review | 25 | |
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis14 | Original article | 24 | |
High-intensity Interval Training Dosage for Heart Failure and Coronary Artery Disease Cardiac Rehabilitation. A Systematic Review and Meta-analysis15 | Original article | 21 | |
Beta-blockers: Historical Perspective and Mechanisms of Action16 | Review | 21 | |
Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design17 | Original article | 21 | |
2020 | Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology18 | Position paper | 59 |
Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology19 | Position paper | 50 | |
Exercising in times of COVID-19: what do experts recommend doing within four walls?20 | Editorial | 37 | |
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience21 | Original article | 30 | |
Arterial thrombotic complications in hospitalized patients with COVID-1922 | Scientific letter | 21 | |
Prevalence of overweight, obesity and abdominal obesity in the Spanish population aged 3 to 24 years. The ENPE study23 | Original article | 14 | |
Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study24 | Original article | 14 | |
Recommendations to improve lipid control. Consensus document of the Spanish Society of Cardiology25 | Position paper | 13 | |
2021 | Acute myocarditis after administration of the BNT162b2 vaccine against COVID-1926 | Scientific letter | 21 |
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry27 | Original article | 15 | |
Spontaneous coronary artery dissection in Spain: clinical and angiographic characteristics, management, and in-hospital events28 | Original article | 11 | |
Markers of myocardial injury in the prediction of short-term COVID-19 prognosis29 | Original article | 8 | |
Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center30 | Original article | 6 | |
Integration of artificial intelligence into clinical patient management: focus on cardiac imaging31 | Review | 5 | |
Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart32 | Original article | 5 | |
Sports-related sudden cardiac death in Spain. A multicenter, population-based, forensic study of 288 cases33 | Original article | 5 | |
Very short dual antiplatelet therapy after PCI and new DES: a meta-analysis of 5 randomized trials34 | Original article | 5 |
Articles receiving an award from the Spanish Society of Cardiology in 2021
1. Prizes awarded by the Spanish Society of Cardiology for articles published inRev Esp Cardiol |
First prize (awarded to 2 articles) Rodríguez-Leor et al. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience. Rev Esp Cardiol. 2020;73:994–1002. Raposeiras-Roubín et al. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction. Rev Esp Cardiol. 2020;73:114-122. |
Second prize Sánchez-Salado et al. Trends in cardiogenic shock management and prognostic impact of type of treating center. Rev Esp Cardiol. 2020;73:546-553. |
2. Prizes awarded by the Spanish Society of Cardiology for the articles published inRev Esp Cardiolwith the greatest international impact |
Most-cited articles, long-term |
First prize Barrios et al. Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study. Rev Esp Cardiol. 2015;68:769:776. |
Second prize Barrabés et al. Prognosis and Management of Acute Coronary Syndrome in Spain in 2012: The DIOCLES Study. Rev Esp Cardiol. 2015;68:98-106. |
Most-cited articles, midterm |
First prize Díaz-Gutierrez et al. The Ratio Between Visceral and Subcutaneous Abdominal Fat Assessed by Computed Tomography Is an Independent Predictor of Mortality and Cardiac Events. Rev Esp Cardiol. 2018;71:357-364. |
Second prize (awarded to 3 articles) Amat-Santos et al. Tricuspid but not Mitral Regurgitation Determines Mortality After TAVI in Patients With Nonsevere Mitral Regurgitation. Rev Esp Cardiol. 2018;71:357-364.Pérez-Castellanos et al. Tako-tsubo Syndrome in Men: Rare, but With Poor Prognosis. Rev Esp Cardiol. 2018;71:703-708.Enríquez-Rodríguez et al. Comparison of the Hemodynamic Performance of the Balloon-expandable SAPIEN 3 Versus Self-expandable Evolut R Transcatheter Valve: A Case-matched Study. Rev Esp Cardiol. 2018;71:735-742. |
3. Prize awarded by the Spanish Society of Cardiology for the best article published inREC: CardioClinics |
Crespo-Leiro et al. One-year prognosis of patients with heart failure in Spain. ESC-EORP-HFA Heart Failure Long-Term Registry. REC CardioClinics. 2020;55:207-216. |
4. Prizes awarded by the Interventional Cardiology Association for the best articles published inREC: Interventional Cardiology |
First prize Rodríguez-Leor et al. Impact of the COVID-19 pandemic on interventional cardiology activity in Spain. REC Interv Cardiol. 2020;2:82-89. |
Second prize Jiménez-Quevedo et al. Time trend in transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry. REC Interv Cardiol. 2020;2:96-105. |
5. Prizes awarded by the Clinical Cardiology Association for the best articles published inRev Esp Cardiol Anguita Sánchez et al. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study. Rev Esp Cardiol. 2020;73:14-20. Díez-Espino et al. Impact of Life's Simple 7 on the incidence of major cardiovascular events in high-risk Spanish adults in the PREDIMED study cohort. Rev Esp Cardiol. 2020;73:205-211. |
6. Prize awarded by the Ischemic Heart Disease and Acute Cardiac Care Association for the best article published inRev Esp Cardiol Sánchez-Salado et al. Trends in cardiogenic shock management and prognostic impact of type of treating center. Rev Esp Cardiol. 2020;73:546-553. |
7. Prize awarded by the Cardiovascular Risk and Rehabilitation Association for the best publication Palau et al. Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction. Rev Esp Cardiol. 2020;73:463-470. |
8. Prize awarded by the Heart Rhythm Association for the best article published inRev Esp Cardiol Jordán-Martínez et al. Atrioventricular block in patients undergoing treatment with bradycardic drugs. Predictors of pacemaker requirement. Rev Esp Cardiol. 2020;73:554-560. |
9. Prize awarded by the Pediatric Cardiology and Congenital Heart Disease Section for the best article published inRev Esp Cardiol Oliver Ruiz et al. Adult congenital heart disease in Spain: health care structure and activity, and clinical characteristics. Rev Esp Cardiol. 2020;73:804-811. |
10. Prize awarded by the Section on Familial Heart Disease and Cardiovascular Genetics for the best article published inRev Esp Cardiol Alonso-Fernández- Gatta et al. A rare HCN4 variant with combined sinus bradycardia, left atrial dilatation, and hypertrabeculation/left ventricular noncompaction phenotype. Rev Esp Cardiol. 2020;74:781-789. |
11. Prize awarded by the Section on Cardiac Pacing on cardiac pacing Moriña-Vázquez et al. Early improvement of leftEarly improvement of left ventricular ejection fraction by cardiac resynchronization through His bundle pacing in patients with heart failure. Europace. 2020;22:125-132. |
12. Ninth Magda Heras prizes for the best article published in an Iberoamerican cardiovascular journal |
First prize Rodríguez-Leor et al. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience. Rev Esp Cardiol. 2020;73:994-1002. |
Second prize Lonis et al. Cardiac remodeling in experimental cardiac failure induced by hyperlipidemia in mice. Rev Chil Cardiol. 2020;39:24-33. |
Third prize Pérez Zerpa et al. Clinical and etiological profile of patients operated on with active endocarditis. Follow-up at 10 years. Rev Urug Cardiol. 2020;35:169-179. |
For the first time in the history of Rev Esp Cardiol, and on the initiative of the previous team and with the support of the Executive Committee of the Spanish Society of Cardiology, the new Editor-in-Chief was chosen through a competitive process. The new Editor-in-Chief (Juan Sanchis) would like to acknowledge the trust placed in him by the selection committee and the Executive Committee of the Spanish Society of Cardiology to lead the new period of Rev Esp Cardiol. In addition, he would like to highlight the eagerness and enthusiasm of the Associate Editors (Pablo Avanzas, David Filgueiras-Rama, Pablo García-Pavía, and Laura Sanchis) forming the new team. Together, we begin this new era with considerable excitement. With the change in the editorial team in October 2021, Dr Pablo Avanzas became Associate Editor and handed over the management of the social media for REC Publications to Dr Juan Quiles. The competition to select the new Editor-in-Chief in February 2021 enabled the new editorial team to be selected months before the de facto change, which occurred in October 2021. This time has allowed an organized transition that has benefited from the outstanding support of both the previous editorial team and the editorial office. We would like to thank the editorial office of REC Publications, managed by Iria del Río and comprising, additionally, Eva M. Cardenal, María González Nogal, Belén Juan, and Helena Gómez-Lobo, who together form one of the most solid cornerstones upon which Rev Esp Cardiol is built.
In addition, we would like to highlight and acknowledge the work of the translation and proofreading teams. The English-language version continues to rely on an experienced team of professionals, comprising Simon Bartlett, Helen Casas, Celine Cavallo, Kevin Clayton, Simon Coxon, Jane Marshall, Greg Morley, and Anne Murray, with Gail Craigie as copy-editor, who have a long relationship with our journal. The professionalism of our translators, their meticulous work, their attention to detail, and their perceptive comments make a strong contribution to the quality of Rev Esp Cardiol. We would also like to use this opportunity to thank the staff members in charge of our journal in Elsevier, particularly Beatriz Mas, Azucena Saavedra, and Toni Rodríguez, for their work and dedication and to all of the departments at the SEC's headquarters, Casa del Corazón, whose work boosts the visibility of the journal.
75 YEARS AT THE HEART OF CARDIOVASCULAR RESEARCHIn 2022, we celebrate the 75th anniversary of our journal. Table 3 lists the various editorial teams that have managed the journal, from its founding to the current team, and Figure 1 shows an image of the first article, published in 1947. Here, we would like to pay tribute to all of the editors, reviewers, authors, translators, proofreaders, and professionals who have collaborated with Rev Esp Cardiol during these 75 years. As mentioned in the statutes of the Spanish Society of Cardiology, Rev Esp Cardiol is the official scientific publication and institutional vehicle of expression of the Spanish Society of Cardiology. It is defined as an “international journal that publishes scientific articles on cardiovascular diseases”. Undoubtedly, the major advantage of Rev Esp Cardiol is the unconditional support of the Spanish Society of Cardiology and the scientifc community behind it. The quality and speed of the peer reviews is undeniable proof of the commitment to our journal. In the last year, the reviews were conducted with an overall time of 8.7 days (9.9 for original articles). We wish to highlight the dedication of our reviewers at a time in which other journals are struggling to find reviewers for their articles. The combined efforts of all involved have allowed Rev Esp Cardiol to achieve its current privileged situation and we would like to use this opportunity to acknowledge the sterling work of those who collaborate with our journal (Table 4), many without even belonging to our Editorial Committee or Advisory Boards, and we highlight the exceptional work of our elite reviewers (Table 5).
Editorial teams* of Rev Esp Cardiol since its founding in 1947
Year | Editor-in-Chief | Associate Editors |
---|---|---|
1947 | Antonio Duque Sampayo | |
1952 | Antonio Duque Sampayo | |
1959 | José de la Hoz Fabra | |
1963 | Justo González Álvarez | |
1967 | Justo González Álvarez | |
1971 | Francisco Pérez Gómez | |
1975 | Leandro Plaza Celemín | |
1977 | Javier Carrillo Kabana | Fermín Bañuelos García |
Antonio Fuertes García | ||
1979 | Juan Luis Delcán Domínguez | Jesús Almendral Garrote |
Luis Martínez Elbal | ||
1982 | José Luis López Sendón | José A. Eizaguirre Pérez |
José M. Oliver Ruiz | ||
1985 | Emilio Marín Huerta | David García Dorado |
Francisco Fernández Avilés | ||
1988 | Emilio Marín Huerta | David García Dorado |
Francisco Fernández Avilés | ||
1991 | Francisco Fernández Avilés | Joaquín Alonso Martín |
Andrés Íñiguez Romo | ||
1996 | Francisco Fernández Avilés | Joaquín Alonso Martín |
Julián Pérez Villacastín | ||
1998 | Xavier Bosch | Joaquín Alonso Martín |
Julián Pérez Villacastín | ||
2001 | Xavier Bosch | Fernando Alfonso |
Julián Pérez Villacastín | ||
2002 | Xavier Bosch | Fernando Alfonso |
Javier Bermejo | ||
2004 | Fernando Alfonso | Javier Bermejo |
Javier Segovia | ||
Magda Heras | ||
2009 | Magda Heras | Pablo Avanzas |
Antoni Bayés-Genís | ||
Leopoldo Pérez de Isla | ||
Juan Sanchis | ||
2015 | Juan Sanchis | Miguel Á. Arias |
Pablo Avanzas | ||
Antoni Bayés-Genís | ||
Ignacio Ferreira-González | ||
Leopoldo Pérez de Isla | ||
2015 | Ignacio Ferreira-González | Emad Abu-Assi |
Miguel Á. Arias | ||
Pastora Gallego | ||
Ángel Sánchez-Recalde | ||
2021 | Juan Sanchis | Pablo Avanzas |
David Filgueiras-Rama | ||
Pablo García-Pavía | ||
Laura Sanchis |
Professionals collaborating as reviewers with Rev Esp Cardiol in 2021
Cesar Abelleira |
Juan Acosta |
Alejandro Adsuar |
Finn Akerström |
Arístides Alarcón |
Dimpna C. Albert |
Manuel Alcázar |
Josep M. Alegret |
Fernando Alfonso |
Luis Almenar |
Manuel Almendro |
Joaquín Alonso |
Pau Alonso |
Gonzalo L. Alonso-Salinas |
Rafael Alonso-González |
Miguel Álvarez |
Teresa Álvarez |
Jesús Álvarez-García |
Ignacio J. Amat |
Dominick Angiolillo |
Ignasi Anguera |
Manuel P. Anguita |
Eduardo Arana |
Albert Ariza |
Pedro Armario |
Ángel Aroca |
Enrique J. Balbacid |
José Banegas |
Jordi Bañeras |
Alfredo Bardají |
Eduardo Barge |
Gonzalo Barge |
José Barrabés |
Manuel Barreiro |
Roberto Barriales |
Vivencio Barrios |
Teresa Bastante |
Javier Bautista |
Antoni Bayés-Genís |
Víctor Bazán |
J. Luis Bernal |
Vicente Bodí |
Alberto Bouzas |
Marisol Bravo |
Montserrat Bret |
María Brión |
Héctor Bueno |
Ramón Calviño |
Francisco E. Calvo |
David Calvo |
Juan Caro |
Amelia Carro |
José Casasnovas |
José M. Castellano |
Pilar Cejudo |
Marinela Chaparro |
Fernando Civeira |
Marta Cobo |
Andrea Colli |
Luciano Consuegra |
Alberto Cordero |
Félix Coserria |
Juan Cosín-Sales |
Eliecer Coto |
David Couto |
Ignacio Cruz |
Héctor Cubero |
Regina Dalmau |
Tomas Datino |
José A. de Agustín |
Jesús M. de la Hera |
José M. de la Torre-Hernández |
Giovanni Luigi De María |
Javier de Miguel |
Irene R. Dégano |
Mónica Delgado |
Juan F. Delgado |
José F. Díaz |
Leonel Díaz-González |
Jesús Díaz-Gutiérrez |
Elena Díaz-Peláez |
Javier Díez |
Pablo Díez-Villanueva |
David Dobarro |
Adelina Doltra |
Laura Domínguez-Pérez |
Fernando Domínguez |
Laura Dos |
Sonia Eiras |
Carlos Escobar |
Laura Escolà-Vergé |
M. Pilar Escribano |
Alberto Esteban-Fernández |
Vicente Estrada |
Artur Evangelista |
Lorenzo Fácila |
Núria Farré |
Ángel L. Fernández |
José A. Fernández-Díaz |
Covadonga Fernández-Golfín |
Nuria Fernández-Hidalgo |
Ignacio Fernández-Lozano |
José L. Ferreiro |
Queralt Ferrer |
Ángela Flox |
Adolfo Fontenla |
José F. Forteza |
María J. Forteza |
Eduardo Franco |
Xavier Freixa |
María Gallego-Delgado |
Ana García-Álvarez |
Ignacio García-Bolao |
Eulogio J. García-Fernández |
Luis García-Guereta |
Alberto García-Lledó |
Xavier García-Moll |
Rocío García-Orta |
José A. García-Robles |
Carlos García Santos-Gallego |
Bruno García del Blanco |
Juan Gimeno |
Manuel Gómez-Bueno |
Juan J. Gómez-Doblas |
Joan A. Gómez-Hospital |
José González-Costello |
Elvira González-Obeso |
Álvaro González-Rocafort |
José M. González-Santos |
Esteban González-Torrecilla |
Esther González |
Teresa González-Alujas |
Antonio González-Calle |
José González-Juanatey |
Violeta González-Salvado |
Francisco González-Vílchez |
Ferrán Gran |
José Guerra |
Carlos Guijarro |
Encarnación Gutiérrez-Carretero |
Enrique Gutiérrez-Ibañes |
Gabriela Guzmán-Martínez |
Ramón Hermida |
Felipe Hernández-Hernández |
Rocío Hinojar |
Ignacio Iglesias-Gárriz |
Javier Inserte |
Carmen Jiménez |
Javier Jiménez-Candil |
Juan Jiménez-Jáimez |
Manuel Jiménez-Navarro |
Justo Juliá |
Alfonso Jurado-Román |
Adnan Kastrati |
Pablo Lázaro |
Pablo Loma-Osorio |
María López |
Esteban López-de-Sá |
Teresa López-Fernández |
José R. López-Mínguez |
Diego López-Otero |
Ramón López-Palop |
Gerard Loughlin |
Íñigo Lozano |
Begoña Manso |
Gerard Martí-Aguasca |
María Martín |
Isaac Martínez-Bendayán |
Sergio Martínez-Hervás |
M. del Mar Martínez-Quesada |
Efrén Martínez-Quintana |
Manuel Martínez-Sellés |
Lluís Masana |
Ana Méndez |
Irene Méndez |
Dolores Mesa-Rubio |
Emilio Monguió |
José M. Montero |
Silvia Montserrat |
Raúl Moreno |
Cesar Morís |
Luis Nombela |
Julio Núñez |
Raymundo Ocaranza |
Soledad Ojeda |
José M. Oliver |
Peter Ong |
Ana Osa |
Joaquín Osca |
Marta Pachón |
Teresa Padró |
Julián Palomino |
Manuel Pan |
Federico Paredes |
Isaac Pascual |
Domingo A. Pascual |
Rafael Peinado |
Pablo Peñafiel |
María L. Peña-Peña |
Leopoldo Pérez de Isla |
Armando Pérez de Prado |
Esther Pérez-David |
Jesús Peteiro |
Antonia Pijuan-Domènech |
Xavier Pintó |
Jesús Piqueras |
Susanna Prat |
Raquel Prieto |
Juan Quiles |
Sergio Raposeiras-Roubín |
Juan J. Ríos |
Fernando Rivero |
Ivo Roca-Luque |
Sergio Rodríguez de Leiras |
Luis Rodríguez-Padial |
Oriol Rodríguez |
Moisés Rodríguez-Mañero |
Ramón Rodríguez-Olivares |
José F. Rodríguez-Palomares |
Nieves Romero |
José Rozado |
Fernando Rueda |
Joaquín Rueda |
Ricardo Ruiz-Granell |
Juan M. Ruiz-Nodar |
Rafael Salguero |
Adriana Saltijeral |
José A. San Román |
Marianela Sánchez-Martínez |
Raúl Sánchez-Pérez |
Pedro L. Sánchez |
Violeta Sánchez |
Enrique Santas |
Gloria Santos |
Ricardo Sanz-Ruiz |
Fernando Sarnago |
Inés Sayago |
Alessandro Sionis |
Javier Suárez de Lezo |
José Suárez de Lezo |
Maite Subirana |
Antonio Tello-Montoliú |
Luis Teruel |
Jorge Toquero |
Aitor Uribarri |
Félix Valencia |
Israel Valverde |
Rafael Vidal |
Isidre Vilacosta |
Gemma Vilahur |
Fernando Worner |
Sergi Yun |
Carlos Zaragoza |
Esther Zorio |
The IF is an imperfect metric of the quality of a journal but, whether we like it or not, it is one of the most commonly used parameters for judging a journal.35 We live in times of uncertainty regarding the formula used to calculate the IF. Thus far, to determine the numerator (citations received by published articles) and denominator (number of citable articles published), the formula has considered only articles published in an issue with their complete citation. The previous year saw the beginning of a transition that will, in the coming years, culminate in the counting of all articles published in their ahead of print (AOP) version instead of the final paginated version. It is not known when this change, which already impacted other journals in 2021, will fully affect Rev Esp Cardiol because the Web of Science, the database used to calculate the IF, does not currently index the AOP content of Rev Esp Cardiol but rather waits until the article is included in a specific issue, in contrast to other platforms such as MEDLINE and ScienceDirect. This is common for journals published by Elsevier, which benefited less from the general increase in the IF published in 2021. During this transition period, we will have to wait to assess the final situation of the IF of Rev Esp Cardiol when all of these changes stabilize. Nonetheless, beyond IF, the objective of a scientific and medical journal should be to publish high-quality articles that are relevant for clinicians and researchers.
NewslettersParalleling the transition toward the use of the AOP version to calculate the IF, the way that scientific content is accessed and consumed has been changing in recent years. Initially, the printed version was the main medium. Subsequently, the focus shifted to websites, where the user periodically reviewed the online content of the new issues. Currently, newsletters with the most recent AOP articles are the main method of dissemination. This approach facilitates the immediate release of information. Consequently, the focus of journals has moved to these newsletters, which is why one of the objectives of the new editorial team is their redesign. In this regard, the bilingual nature of the journal represents a further challenge. The articles accepted in Rev Esp Cardiol are available AOP in the original submission language and then in the translated version. The wait to have both versions available for their dissemination in the newsletter constitutes an excessive delay. However, dissemination when only the first version of the article is ready means that the translation is not simultaneously available and, in addition, that each newsletter would mix Spanish- and English-language articles. We will consider the advantages and disadvantages of all factors when studying all of the options to create the most attractive newsletter possible.
Publication timesThe acceptance of an article is followed by 2 phases: a) from acceptance to publication of the AOP version; and b) from AOP publication to publication in an issue of Rev Esp Cardiol. In the first phase, we need to format and translate the article and apply the required corrections. This step takes about 2 months in each language, which means a total delay of 4 months until the AOP article is published in both languages. In the second phase, the publisher must prepare the article for its inclusion in an issue of Rev Esp Cardiol, which requires another 2 months. The issue of Rev Esp Cardiol in which the article will be published ultimately depends on the volume of articles awaiting publication. Thus, the actual time from the acceptance of an original article to its publication in a specific issue is 10 months. This delay has been falling in recent years due to the efforts of the editorial office, editors, and publisher. Our objective is to continue to reduce timelines, whenever it is possible to do so without compromising the excellent production quality of Rev Esp Cardiol. We believe that the critical period to shorten is the time from acceptance to AOP publication. The objective is to satisfy the general desire of authors to see their articles published as soon as possible, which is particularly important for articles reporting novelties.
Training in Rev Esp CardiolThe current team of editors considers the educational role of Rev Esp Cardiol to be essential. It is a genuine challenge to reconcile this objective with IF metrics. Nonetheless, IF should not be the only parameter guiding the journal's strategy. In addition to continuing with the policy of the previous team of publishing special articles on topics of particular interest,31,36–42 we are beginning a partnership with the League of Clinical Cases of the Spanish Society of Cardiology43 to publish clinical cases, which will be accompanied by an editorial comment with a largely educational focus. In addition, we will attempt to entice residents and young cardiologists to conduct research and to write scientific articles through in-person or online courses or seminars focused on how to design a scientific project and write an article.
REC Publications familyIn 2019, the REC Publications family of journals was created, which comprises Rev Esp Cardiol and 2 new journals, REC: Interventional Cardiology44 and REC: CardioClinics.45REC: Interventional Cardiology is focused on catheterization and interventional cardiology and their related heart diseases, whereas REC: CardioClinics addresses the entire cardiology spectrum.46,47 Both journals are currently in the difficult initial stages in which they are attempting to be indexed by the most important repositories. We must praise the tremendous efforts of their editorial teams in this launching phase. From this “Editor's page”, we would like to encourage authors to submit articles to both journals, either through direct submission or by accepting a transfer suggestion when an article unfortunately cannot be accepted in Rev Esp Cardiol. An overriding objective of Rev Esp Cardiol, and which we relay to all cardiologists, is to facilitate the submission of articles to REC: Interventional Cardiology and REC: CardioClinics as soon as possible.
In conclusion, in this first “Editor's page” of the new editorial team, we would like to express our enthusiasm for the new project and set as initial objectives the reimagining of newsletters, the optimization of publication times without compromising quality, the strengthening of the educational objectives of the journal, and the advancement of the REC Publications family. We hope that this project can count on your interest while also asking you for any suggestions that you might have.
FUNDINGNone declared.
CONFLICTS OF INTERESTNone declared.
.